Vraylar 1.5 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FA0Q0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,024
Award facts
- Contract value 100% obligated
- $24,023.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $24,023.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp for VRAYLAR 1.5 MG capsules (30-count units) on December 22, 2025, with an ultimate completion date of December 23, 2025. This non-set-aside contract was competitively awarded and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, supplies a comprehensive range of pharmaceutical products and medical supplies to military and veteran healthcare systems through the DLA Medical Supply Chain. The broader IDC encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains, supporting customers including the Defense Health Agency and U.S. Coast Guard. VRAYLAR is a neurological treatment medication, consistent with AmerisourceBergen's extensive portfolio of pharmaceutical deliveries across various therapeutic areas under federal contract.
Quick answers
Who was awarded contract SPE2DR26FA0Q0?
SPE2DR26FA0Q0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26FA0Q0 worth?
The government has obligated $24,024 on SPE2DR26FA0Q0.
Is contract SPE2DR26FA0Q0 an order under another contract?
Yes. SPE2DR26FA0Q0 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA0Q0 competed?
The extent of competition for SPE2DR26FA0Q0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award